Skip To Main Content
Yingwei Wang on Muck Rack

Yingwei Wang

As seen in: AIChE Journal, Color Research & Application, Nature, Wiley Online Library, PLOS, Frontiers, MDPI, Taylor & Francis Online, ACS Publications, BMC Cancer and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yingwei

Contact Yingwei, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

H 2 S-induced surface reconstruction enables efficient CsPbI 3 QLEDs with ultralow roll-off

|
By Wanying Zhang, Jie Chen, Mengjie Li, Tongtong Wang, Xinyang Zhang, Yiran Zhao, Yingwei Wang, Fan Xia, Keqiang Chen, Guogang Li, Xuanyang He
| Nature Verified
Abstract Metal halide perovskite quantum dots (QDs) are promising materials for developing low-cost and high-performance quantum dot-based light-emitting diodes (QLEDs). Despite external quantum efficiency (EQE) comparable to II–VI/III–V QLEDs, perovskite QD counterparts achieve peak EQE at low luminance/current density and exhibit significantly more pronounced efficiency roll-off, owing primarily to their ionic character and soft lattice.
Open in Who Shared Issue with article?

Safety and efficacy of the combination of hyperbaric oxygen and 177 Lu-DOTA-IBA in treating metastatic bone pain due to tumors

|
By Yingwei Wang, Ya Liu, Jian Yang, Dengsai Peng, Qingchu Hua, Chunfang Zhang, Ying Zhang, Wei Wang, Yue Chen
| Nature Verified
Abstract The efficacy of the combination of hyperbaric oxygen therapy and the radionuclide treatment in targeting and treating metastatic bone pain due to tumors was analyzed in this study. Thirty-nine patients with metastatic bone tumors were divided into 2 groups. Group A consisted of patients receiving hyperbaric oxygen therapy combined with radionuclide therapy, and group B had patients receiving radionuclide therapy alone.
Open in Who Shared Issue with article?

Evaluation of 161 Tb-Labeled DOTA-Ibandronate for Targeted Radionuclide Therapy in Bone Metastases Click to copy article link Article link copied!

|
By Chunfang Zhang, Yingwei Wang, Jia Deng
| ACS Publications
Abstract Click to copy section linkSection link copied! Building upon our previous work on [68Ga]Ga/[177Lu]Lu-DOTA-Ibandronate and its demonstrated clinical applicability, this study investigates the biological behavior and translational potential of the novel therapeutic radiopharmaceutical terbium-161 (161Tb)-labeled DOTA-IBA. The radiolabeling parameters of [161Tb]Tb-DOTA-IBA were first optimized, followed by a systematic assessment of its physicochemical characteristics.
Open in Who Shared Issue with article?
See all 57 articles